Predictive immune biomarkers to safely discontinue nucleos (t)ide analogue treatment in HBeAg negative chronic hepatitis B (NUC-B study)

This article has no abstract
Epistemonikos ID: 79bf634d7f8cbbd5ddf8f9987932369fd00b9886
First added on: Feb 14, 2025